Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Deciding which card is better, cash back or rewards, requires consideration of your spending habits. Make the right choice for your finances.
26,157 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
AMD sits near a pivotal $420 level as first-quarter results underscore strong data-center demand and a bold AI-driven...
May 2026 data show mortgage lock volume slid 9% from April as higher rates cooled demand. Purchases led the market, w...
The crypto market braced for headlines as Circle faced talk of an open USD threat. Analysts argue the pullback in CRC...
A single hedge fund exit can move a stock as much as a major earnings beat. This guide breaks down a $34 million TDS ...
Three months into 2026, the 2.8% COLA boosted average benefits to $2,071, but a surge in energy prices and Medicare w...
Arm Holdings has surged 104% year-to-date, with the AI pivot and AGI CPU driving demand. Smart money sits near a spec...
U.S. equities sit near record highs as AI spending fuels gains, but a growing chorus on Wall Street warns that federa...
Public moments can shift finances as quickly as headlines change. This article uses adele’s rare return sparks as a s...
D-Wave Quantum stock gained momentum this week as investors weighed upcoming results and potential partnerships. This...
Tether converts a historic $13 billion profit into a bold health-tech investment, backing Eight Sleep at a $1.5 billi...
A sweeping shift in government-backed tech funding is changing how investors value IBM and Intel. Taxpayers, once dis...